https://www.celltrionusa.com/history-event/celltrion-founded/ 2026-02-05T00:59:43+00:00 https://www.celltrionusa.com/history-event/plant-1-receives-cgmp-facility-approval-by-us-fda/ 2026-02-20T00:02:11+00:00 https://www.celltrionusa.com/history-event/initial-public-offering-ipo/ 2026-02-20T00:02:34+00:00 https://www.celltrionusa.com/history-event/plant-2-90000l-completed/ 2026-02-20T00:03:01+00:00 https://www.celltrionusa.com/history-event/remsima-receives-approval-by-korea-mfds/ 2026-02-20T00:03:23+00:00 https://www.celltrionusa.com/history-event/plant-1-2-receive-approval-by-us-fda-on-all-cgmp-manufacturing-facilities/ 2026-02-20T00:04:17+00:00 https://www.celltrionusa.com/history-event/remsima-receives-approval-by-us-fda/ 2026-02-20T00:04:46+00:00 https://www.celltrionusa.com/history-event/truxima-receives-approval-by-europe-ema/ 2026-02-20T00:05:25+00:00 https://www.celltrionusa.com/history-event/temixys-receives-approval-by-us-fda/ 2026-02-20T00:05:48+00:00 https://www.celltrionusa.com/history-event/remsima-sc-receives-approval-by-europe-ema/ 2026-02-20T00:06:41+00:00 https://www.celltrionusa.com/history-event/expansion-of-plant-1-additional-50000l-completed/ 2026-02-20T00:07:09+00:00 https://www.celltrionusa.com/history-event/reached-krw-1-trillion-in-annual-sales/ 2026-02-20T00:07:32+00:00 https://www.celltrionusa.com/history-event/acquired-primary-care-product-assets-for-asia-pacific-markets-from-takeda-ltd/ 2026-02-20T00:07:53+00:00 https://www.celltrionusa.com/history-event/yuflyma-receives-approval-by-europe-ema/ 2026-02-20T00:08:15+00:00 https://www.celltrionusa.com/history-event/regkirona-receives-approval-by-europe-ema/ 2026-02-20T00:08:37+00:00 https://www.celltrionusa.com/history-event/vegzelma-receives-approval-by-europe-ema/ 2026-02-20T00:09:04+00:00 https://www.celltrionusa.com/history-event/vegzelma-receives-approval-by-us-fda/ 2026-02-20T00:09:24+00:00 https://www.celltrionusa.com/history-event/yuflyma-receives-approval-by-us-fda/ 2026-02-20T00:09:47+00:00 https://www.celltrionusa.com/history-event/zymfentra-remsima-sc-received-fda-approval-as-novel-therapeutics/ 2026-02-20T00:10:06+00:00 https://www.celltrionusa.com/history-event/celltrion-inc-celltrion-healthcare-co-ltd-merger-completed/ 2026-02-20T00:10:23+00:00 https://www.celltrionusa.com/history-event/avtozma-receives-approval-by-us-fda/ 2026-02-20T00:11:08+00:00 https://www.celltrionusa.com/history-event/omlyclo-receives-approval-by-us-fda/ 2026-02-20T00:11:26+00:00 https://www.celltrionusa.com/history-event/eydenzelt-receives-approval-by-us-fda/ 2026-02-20T00:11:41+00:00 https://www.celltrionusa.com/history-event/acquisition-of-the-branchburg-manufacturing-facility-66000l/ 2026-02-20T00:12:00+00:00 https://www.celltrionusa.com/history-event/herzuma-receives-approval-by-us-fda/ 2026-02-20T00:46:01+00:00 https://www.celltrionusa.com/history-event/steqeyma-fda-approved/ 2026-02-24T23:09:56+00:00 https://www.celltrionusa.com/history-event/supply-agreement-with-bristol-myers-squibb/ 2026-02-24T23:12:03+00:00 https://www.celltrionusa.com/history-event/plant-1-50000l-completed/ 2026-02-24T23:12:09+00:00 https://www.celltrionusa.com/history-event/remsima-receives-approval-by-europe-mfds/ 2026-02-24T23:12:49+00:00